What companies are DUL.DE's competitors?

Alnylam Pharmaceuticals, Inc. (DUL.DE)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does DUL.DE compare to its peers?

The peer comparison table on this page shows Alnylam Pharmaceuticals, Inc. (DUL.DE) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does DUL.DE operate in?

Alnylam Pharmaceuticals, Inc. (DUL.DE) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

DUL.DE

Alnylam Pharmaceuticals, Inc.

XETRA·Biotechnology · Healthcare

€237.25€1.00−0.42%

Market cap€31.68B·Market closed·Jul 22 7:44 AM UTC

Frequently Asked Questions About DUL.DE

What companies are DUL.DE's competitors?: Alnylam Pharmaceuticals, Inc. (DUL.DE)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does DUL.DE compare to its peers?: The peer comparison table on this page shows Alnylam Pharmaceuticals, Inc. (DUL.DE) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does DUL.DE operate in?: Alnylam Pharmaceuticals, Inc. (DUL.DE) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

DUL.DE

Alnylam Pharmaceuticals, Inc.

XETRA·Biotechnology · Healthcare

€237.25€1.00−0.42%

Market cap€31.68B·Market closed·Jul 22 7:44 AM UTC

Peers


VX1.DE	Vertex Pharmaceuticals Incorporated	€422.05	€107.1B
CGN.DE	Cigna Corporation	€255.60	€67.6B
MRK.DE	Merck KGaA	€134.35	€58.4B
BAYN.DE	Bayer Aktiengesellschaft	€46.68	€45.9B
SHL.DE	Siemens Healthineers AG	€34.52	€38.6B
ZOE.DE	Zoetis Inc.	€66.22	€27.8B
VEE.DE	Veeva Systems Inc.	€168.50	€27.4B
0QF.F	Moderna, Inc.	€51.78	€20.5B
22UA.F	BioNTech SE	€80.90	€20.5B
2VSA.F	Verastem, Inc.	€4.94	€342.1M

Frequently Asked Questions About DUL.DE

What companies are DUL.DE's competitors?: Alnylam Pharmaceuticals, Inc. (DUL.DE)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does DUL.DE compare to its peers?: The peer comparison table on this page shows Alnylam Pharmaceuticals, Inc. (DUL.DE) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does DUL.DE operate in?: Alnylam Pharmaceuticals, Inc. (DUL.DE) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.